Robinson Cole LLP
High Contrast Mode

Data, Technology & Artificial Intelligence

Nicole M. Diodati assists clients with data and technology licensing, development, acquisition, maintenance, and servicing agreements. Specifically, in connection with technology licensing, she assists clients with a wide variety of agreements necessary to protect and exploit technology such as professional services and development contracts, nondisclosure and inventions assignment agreements, and license agreements. Nicole also represents clients licensing data and software by advising on and negotiating data licenses, software licenses, cloud services and software as a service (SaaS) agreements.

Intellectual Property

Nicole’s practice primarily involves advising clients on the development, protection, and commercialization of various forms of intellectual property.

  • Nicole assists clients with trademark, patent, and copyright development and intellectual property licensing and assignment agreements in various industries.
  • Nicole has aided clients with packaging, labeling, promotional, and advertising compliance matters.
  • Nicole has aided clients with all aspects of a new product launch, including drafting development agreements, and various commercial agreements, including  terms and conditions of use, purchase and sale.
  • Nicole assists clients with brand management matters including clearance, prosecution, maintenance and enforcement of trademark registrations and rights worldwide. Nicole also aids clients with resolution of ownership and rights disputes including assisting with U.S. Patent and Trademark Office opposition and cancellation proceedings.

Nicole has experience assisting national and multinational companies across various industries with the intellectual property and technology aspects of mergers and acquisitions, both sell-side and buy-side and ranging in value.

Prior to joining Robinson+Cole, Nicole focused her practice on insurance claims transactions involving data privacy, cybersecurity, information technology, and compliance. Nicole is a Certified Information Privacy Professional (CIPP/US).

During law school, Nicole ranked in the top 15% of her graduating class and was an honors judicial intern for the Honorable Edgardo Ramos of the U.S. District Court for the Southern District of New York.

  • Pace University School of Law (Juris Doctor, magna cum laude)
    • Pace International Law Review, Note and Comment Editor
    • Full-Tuition Merit Scholarship
    • Dean’s List
  • Marist University (Bachelors, summa cum laude)
    • B.S., Business Administration and Finance
    • Hudson Valley Scholarship
    • Dean’s List

  • State of Connecticut
  • State of New Jersey
  • State of New York

Presented with the 2024 U.S.A. Deal of the Year award, in the small markets category, as part of the Global M&A Network's 15th Annual Americas and Global Markets M&A Atlas Awards in recognition of the acquisition of Medacist Solutions Group by Bluesight, the Medication Intelligence™ Company.

New York State Bar Association

New Jersey State Bar Association

New York City Bar Association
Trademark & Unfair Competition Committee (September 2023 -  August 2026)
 

Westchester Women's Bar Association

Dutchess County Bar Association

Certified Information Privacy Professional (CIPP/US)

Publications


Legal Update: Section 1782: Discovery in Support of a Foreign Proceeding teaser
May 18, 2022

Legal Update: Section 1782: Discovery in Support of a Foreign Proceeding

Legal Update: Section 1782: Discovery in Support of a Foreign Proceeding teaser
May 18, 2022

Legal Update: Section 1782: Discovery in Support of a Foreign Proceeding


News


June 12, 2026

Capital Markets Team Represents Horizon Space Acquisition in Business Combination

Robinson+Cole’s Capital Markets + Securities group represented Horizon Space Acquisition II Corp. (Nasdaq: HSPT), a publicly traded special purpose acquisition company, in the closing of its business combination with SL BIO Ltd., a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies. The team advising on the transaction was led by Capital Markets + Securities group partner Arila Zhou, and included members Ze’-ev Eiger, Emmett Tan and Chenyi Wang, with support from Intellectual Property + Technology group lawyers Jackie Pennino Scheib and Nicole M. Diodati. Read the press release, here.

December 18, 2025

Business Transactions in Health Care Team Wins “Pharma & Devices Deal of the Year” at Global M&A Network’s 7th Annual USA Middle Markets M&A Atlas Awards Gala

Global M&A Network
Business Transactions in Health Care Team Wins “Pharma & Devices Deal of the Year” at Global M&A Network’s 7th Annual USA Middle Markets M&A Atlas Awards Gala teaser
May 16, 2025

Capital Markets + Securities Group Represents Horizon Space Acquisition II in Business Combination with SL Bio

June 12, 2026

Capital Markets Team Represents Horizon Space Acquisition in Business Combination

Robinson+Cole’s Capital Markets + Securities group represented Horizon Space Acquisition II Corp. (Nasdaq: HSPT), a publicly traded special purpose acquisition company, in the closing of its business combination with SL BIO Ltd., a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies. The team advising on the transaction was led by Capital Markets + Securities group partner Arila Zhou, and included members Ze’-ev Eiger, Emmett Tan and Chenyi Wang, with support from Intellectual Property + Technology group lawyers Jackie Pennino Scheib and Nicole M. Diodati. Read the press release, here.

December 18, 2025

Business Transactions in Health Care Team Wins “Pharma & Devices Deal of the Year” at Global M&A Network’s 7th Annual USA Middle Markets M&A Atlas Awards Gala

Global M&A Network
Business Transactions in Health Care Team Wins “Pharma & Devices Deal of the Year” at Global M&A Network’s 7th Annual USA Middle Markets M&A Atlas Awards Gala teaser
May 16, 2025

Capital Markets + Securities Group Represents Horizon Space Acquisition II in Business Combination with SL Bio

April 10, 2025

Mergers + Acquisitions Team Represents Tradebe Life Sciences in Florachem Acquisition

September 27, 2024

Capital Markets + Securities Team Represents Acri Capital Acquisition Corp. in Business Combination

The Wall Street Journal
July 19, 2024

Robinson+Cole Represents Vast Medical Group in Investment by Sumitomo Corporation

July 1, 2024

Nicole Diodati Appointed to Fall Kill Creative Works’ Board of Directors

Fall Kill Creative Works
June 24, 2024

Capital Markets + Securities Team Represents Feutune Light Acquisition Corporation in the Closing of its Business Combination with Thunder Power Holdings Limited

February 28, 2024

Robinson+Cole Deal Team Recognized During Global M&A Network's 2024 15th Annual Americas and Global Markets M&A Atlas Awards

Global M&A Network
Robinson+Cole Deal Team Recognized During Global M&A Network's 2024 15th Annual Americas and Global Markets M&A Atlas Awards teaser

April 10, 2025

Mergers + Acquisitions Team Represents Tradebe Life Sciences in Florachem Acquisition

September 27, 2024

Capital Markets + Securities Team Represents Acri Capital Acquisition Corp. in Business Combination

The Wall Street Journal
July 19, 2024

Robinson+Cole Represents Vast Medical Group in Investment by Sumitomo Corporation

July 1, 2024

Nicole Diodati Appointed to Fall Kill Creative Works’ Board of Directors

Fall Kill Creative Works
June 24, 2024

Capital Markets + Securities Team Represents Feutune Light Acquisition Corporation in the Closing of its Business Combination with Thunder Power Holdings Limited

February 28, 2024

Robinson+Cole Deal Team Recognized During Global M&A Network's 2024 15th Annual Americas and Global Markets M&A Atlas Awards

Global M&A Network
Robinson+Cole Deal Team Recognized During Global M&A Network's 2024 15th Annual Americas and Global Markets M&A Atlas Awards teaser